Management of psoriasis in pregnancy


  • Conflict of Interest Information: Bruce Strober has been a principal investigator, an advisor or consultant, or a speaker for the following groups: Abbott, Amgen, Celgene, Janssen, Maruho, Novartis, Pfizer and UBC.

Address correspondence and reprint requests to: Bruce Strober, MD PhD, Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT 06030, or email:


Psoriasis is an inflammatory skin disorder not uncommonly seen in pregnant patients. Several drugs have been approved for its treatment in non-pregnant patients, but special precautions are necessary when selecting a treatment plan during pregnancy to prevent harm to the fetus and child. This article reviews the treatment options for the treatment of psoriasis in the pregnant and lactating patient.